A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm

Completed

Phase 1/2 Results

Summary of Purpose

To determine whether HMG-CoA reductase inhibitor simvastatin prevents or ameliorates subarachnoid hemorrhage-induced delayed vasospasm and its ischemic consequences.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 October 2008.

1 Dec 2002 7 Oct 2005 1 Jan 2006 1 Feb 2006 1 Oct 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Guy Rordorf, M.D. Massachusetts General Hospital Boston, Massachusetts 02114

    cayata@partners.org